Passive immunization (procedure)
| Code | 51116004 |
|---|---|
| Semantic tag | procedure |
| Module | international |
| Definition | defined |
| Effective time | 20200731 |
127785005Active or passive immunisation
procedure
116762002Administration of blood product
procedure
722334000Adalimumab therapy
procedure
27513008Administration of antitoxin
procedure
1208464009Administration of bebtelovimab
procedure
1162712003Administration of casirivimab
procedure
870534008Administration of human anti-D immunoglobulin
procedure
117103007Administration of human immune globulin product
procedure
1162713008Administration of imdevimab
procedure
48556009Administration of immune serum
procedure
698802001Administration of immunoglobulin by intravenous route
procedure
1179729003Administration of sarilumab
procedure
1162711005Administration of sotrovimab
procedure
1179723002Administration of tocilizumab
procedure
339702231000119109Anifrolumab therapy
procedure
1269443006Belantamab mafodotin therapy
procedure
726601008Belimumab therapy
procedure
352132381000119101Canakinumab therapy
procedure
726602001Certolizumab pegol therapy
procedure
311780005Continuous infusion of immunoglobulin
procedure
700139004Denosumab therapy
procedure
723946003Golimumab therapy
procedure
1269445004Guselkumab therapy
procedure
713517003Infliximab therapy
procedure
396241000119104Injection of indium 111 and ibritumomab tiuxetan
procedure
713534006Injection of normal human immunoglobulin
procedure
180244008Intramuscular immunotherapy
procedure
1269441008Ixekizumab therapy
procedure
466579201000119109Mepolizumab therapy
procedure
782710000Natalizumab therapy
procedure
860788002Ocrelizumab therapy
procedure
271498007Rabies human immune globulin injection
procedure
118640001Radioimmunotherapy
procedure
1287683007Risankizumab therapy
procedure
724159000Rituximab therapy
procedure
782711001Secukinumab therapy
procedure
16609791000119102Transfusion of immunoglobulin
procedure
726598003Ustekinumab therapy
procedure
782712008Vedolizumab therapy
procedure